KLAS Contact
Contact KLAS
Contact KLAS
2024 BEST IN KLAS
Preferences
Related Series
2020
2017
2015
2014
Related Segments
340B Management Systems 2024
Are Vendors Driving Savings in a High-Energy Market?
Author
Jackson Tate
Author
Jennifer Hickenlooper
Author
Lance Merrell
A market with consistently high energy, 340B programs remain top of mind for eligible healthcare organizations as they try to drive cost savings for both their organization and their patients. With increasing drug manufacturer restrictions and the possibility of additional legislation down the road, organizations continue to look to their 340B management vendors for tools and expertise to help navigate this space. This report examines customer satisfaction with 340B management vendors by looking at factors such as use by different customer types, customer ability to find savings and get their money’s worth, strength of vendor support, and vendor guidance in managing evolving challenges.
If you don't have a login, getting started is easy.
Key Findings:
- Verity Solutions & PharmaForce Drive Savings & High Customer Satisfaction; PharmaForce’s Acute-Care Focus Results in More Variability for Ambulatory Customers
- Verity Solutions & RxStrategies* Provide Strong Account Management; Some Macro Helix Customers Deciding to Leave due to Support Challenges
- The Craneware Group Customers See Less Value for Solution’s Cost; Macro Helix Customers Appreciate Multiple Options for Pricing Structures, Some Feel Nickel-and-Dimed
- Across Vendors, Customers Want More Help Navigating Drug Manufacturer Restrictions; Automated Tools & Strong Service Are Highlighted for Easing Provider Burden
*Limited data
Writer
Carlisa Cramer
Designer
Nikki Christensen
Project Manager
Andrew Wright
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.